INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Coty Inc. - COTY

28.09.25 16:00 Uhr

Werte in diesem Artikel
Aktien

3,35 EUR 0,03 EUR 0,90%

NEW YORK, Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. ("Coty" or the "Company") (NYSE: COTY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.  

Fighting for victims of securities fraud for more than 85 years (PRNewsfoto/Pomerantz LLP)

The investigation concerns whether Coty and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action]

On August 20, 2025, Coty issued a press release reporting its financial results its full fiscal year 2025 and fourth quarter.  Among other items, Coty reported an unexpected loss and provided disappointing guidance.  Discussing the results on an earnings call, Coty's Chief Financial Officer said that "[t]he challenges of fiscal year 2025 coincided with moderating profit in the broader beauty market," attributing sluggish sales to factors ranging from value-seeking behavior, innovation fatigue by consumers, and anti-theft and immigration policy changes. 

On this news, Coty's stock price fell $1.05 per share, or 21.6%, to close at $3.81 per share on August 21, 2025.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, London, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes. 

CONTACT:
Danielle Peyton
Pomerantz LLP
dpeyton@pomlaw.com
646-581-9980 ext. 7980

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-coty-inc--coty-302567932.html

SOURCE Pomerantz LLP

In eigener Sache

Übrigens: Coty A und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Coty A

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Coty A

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Coty Inc (A)

Wer­bung

Analysen zu Coty Inc (A)

DatumRatingAnalyst
16.11.2018Coty A OutperformBMO Capital Markets
24.08.2018Coty A Market PerformBMO Capital Markets
16.12.2016Coty A OutperformBMO Capital Markets
24.10.2016Coty A BuyStifel, Nicolaus & Co., Inc.
29.09.2016Coty A NeutralB. Riley & Co., LLC
DatumRatingAnalyst
16.11.2018Coty A OutperformBMO Capital Markets
24.08.2018Coty A Market PerformBMO Capital Markets
16.12.2016Coty A OutperformBMO Capital Markets
24.10.2016Coty A BuyStifel, Nicolaus & Co., Inc.
04.05.2016Coty A BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
29.09.2016Coty A NeutralB. Riley & Co., LLC
05.05.2016Coty A Equal WeightBarclays Capital
21.07.2015Cot a Sector PerformRBC Capital Markets
10.11.2014Cot a NeutralB. Riley & Co., LLC
08.10.2014Cot a NeutralB. Riley & Co., LLC
DatumRatingAnalyst
14.08.2015Cot a SellB. Riley & Co., LLC
26.03.2015Cot a SellB. Riley & Co., LLC
19.09.2014Cot a SellB. Riley & Co., LLC

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Coty Inc (A) nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen